荧光示踪前哨淋巴结与淋巴造影:EURO-FIGS登记研究结果
该研究基于EURO-FIGS前瞻性登记数据,纳入10个中心18位外科医生治疗的188例胃肠道肿瘤患者,评估ICG引导的近红外荧光前哨淋巴结导航与淋巴造影效果。结果显示75.5%病例荧光导航阳性,阳性前哨淋巴结检出率95.5%,转移率14.7%,52.1%病例在标准淋巴清扫范围外检出淋巴结,其中43.8%存在转移。
要点
- ICG荧光导航可检出标准淋巴清扫范围外的潜在转移淋巴结。
- 阳性前哨淋巴结识别是标准范围外转移的独立预测因素(OR=4.392)。
- 较低ICG剂量与标准范围外荧光识别减少相关(OR=0.596)。
核心结论
- 前哨淋巴结示踪有助于识别标准淋巴清扫范围外的潜在转移淋巴结。
- EURO-FIGS登记是分享和分析欧洲外科医生实践的有价值工具。
研究设计与样本
- 前瞻性收集EURO-FIGS登记中患者及ICG引导淋巴清扫数据进行分析。
- 共纳入188例患者,来自10个中心的18位外科医生。
主要发现
- 结直肠癌占77.7%,胃癌占19.1%,食管肿瘤占3.2%。
- NIRF前哨淋巴结导航总体阳性率为75.5%,阳性前哨淋巴结检出率为95.5%,转移率为14.7%。
- 52.1%病例在标准淋巴站之外检出淋巴结,其中43.8%为转移阳性。
- 阳性NIRF前哨淋巴结识别是标准淋巴站外转移的独立预测因素(OR=4.392,p=0.029)。
- BMI独立预测检出前哨淋巴结的转移(OR=1.187,p=0.013)。
关键数值与推荐
- ICG经腔外途径注射剂量更高(p<0.001),经腔内途径注射体积更大(p<0.001)。
- 较低ICG剂量对标准淋巴清扫范围外NIRF识别具有保护作用(OR=0.596,p=0.006)。
- 较高ICG体积预测标准淋巴清扫范围外转移受累(OR=1.597,p=0.001)。
临床怎么用
- 在胃肠道肿瘤手术中可考虑使用ICG近红外荧光成像进行前哨淋巴结导航和淋巴造影。
- 荧光导航有助于发现标准淋巴清扫范围外的淋巴结,可能改善淋巴结分期。
局限性
- 本研究为登记数据分析,非随机对照试验,存在选择偏倚可能。
- 样本量有限(188例),且以结直肠癌为主,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The identification of metastatic lymph nodes is one of the most important prognostic factors in gastrointestinal (GI) cancers. Near-infrared fluorescence (NIRF) imaging has been successfully used in GI tumors to detect the lymphatic pathway and the sentinel lymph node (SLN), facilitating fluorescence image-guided surgery (FIGS) with the purpose to achieve a correct nodal staging. The aim of this study was to analyze the current results of NIRF SLN navigation and lymphography through data collected in the EURO-FIGS registry. METHODS: Prospectively collected data regarding patients and ICG-guided lymphadenectomies were analyzed. Additional analyses were performed to identify predictors of metastatic SLN and determinants of fluorescence positivity and nodal metastases outside the boundaries of standard lymphadenectomies. RESULTS: Overall, 188 patients were included by 18 surgeons from 10 different centers. Colorectal cancer was the most reported pathology (77.7%), followed by gastric (19.1%) and esophageal tumors (3.2%). ICG was injected with higher doses (p < 0.001) via extraparietal side (63.3%), and with higher volumes (p < 0.001) via endoluminal side (36.7%). Overall, NIRF SLN navigation was positive in 75.5% of all cases and 95.5% of positive SLNs were retrieved, with a metastatic rate of 14.7%. NIRF identification of lymph nodes outside standard lymphatic stations occurred in 52.1% of all cases, 43.8% of which were positive for metastatic involvement. Positive NIRF SLN identification was an independent predictor of metastasis outside standard lymphatic stations (OR = 4.392, p = 0.029), while BMI independently predicted metastasis in retrieved SLNs (OR = 1.187, p = 0.013). Lower doses of ICG were protective against NIRF identification outside standard of care lymphadenectomy (OR = 0.596, p = 0.006), while higher volumes of ICG were predictive of metastatic involvement outside standard of care lymphadenectomy (OR = 1.597, p = 0.001). CONCLUSIONS: SLN mapping helps identifying potentially metastatic lymph nodes outside the boundaries of standard lymphadenectomies. The EURO-FIGS registry is a valuable tool to share and analyze European surgeons' practices.
引用
- Picchetto A, Cinelli L, Bannone E, et al. Fluorescence-based sentinel lymph node mapping and lymphography evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry. Surg Endosc. 2023. PMID: 37043006. doi:10.1007/s00464-023-10043-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。